🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07355049
Starting soon Not applicable

The Effect of Dexmedetomidine Versus Lidocaine on Emergence Agitation.

NCT07355049 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-12-21
Last updated
2026-01-21

Condition(s) studied

Emergence Agitation

Investigational drug(s) / intervention(s)

Dexmedetomidine →Lidocaine →

Dexmedetomidine: Group (D) recieves Dexmedetomidine bolus 1mcg/kg over 10 minutes before induction of anesthesia followed by continous infusion at 0.4 mcg/kg/h until the end of surgery

Lidocaine: Group (L) recieves IV lidocaine 1.5 mg/kg slowly before induction of anesthesia then lidocaine infusion starts at a rate of 2mg/kg/h

Study summary

The effect of intravenous dexmedetomidine versus intravenous lidocaine on the emergence agitation after endoscopic sinus surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Age : 18-60 * ASA Physical Status I or II * Elective endoscopic sinus surgery under general anesthesia . Exclusion Criteria: * Refusal to participate * Mental retardation or inability to communicate * Allergy to anesthetics or study medications . * Chronic use of beta blockers . * significant hepatic, neurologic, cardiovascular or respiratory disease . * BMI\>35 kg/m2

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
FayoumU Al Fayyum Egypt

More Fayoum University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07355049 on ClinicalTrials.gov ↗ ← All trials in Egypt